Cargando…

A retro-inverso cell-penetrating peptide for siRNA delivery

BACKGROUND: Small interfering RNAs (siRNAs) are powerful tools to control gene expression. However, due to their poor cellular permeability and stability, their therapeutic development requires a specific delivery system. Among them, cell-penetrating peptides (CPP) have been shown to transfer effici...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaissière, Anaïs, Aldrian, Gudrun, Konate, Karidia, Lindberg, Mattias F., Jourdan, Carole, Telmar, Anthony, Seisel, Quentin, Fernandez, Frédéric, Viguier, Véronique, Genevois, Coralie, Couillaud, Franck, Boisguerin, Prisca, Deshayes, Sébastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410048/
https://www.ncbi.nlm.nih.gov/pubmed/28454579
http://dx.doi.org/10.1186/s12951-017-0269-2
_version_ 1783232594626740224
author Vaissière, Anaïs
Aldrian, Gudrun
Konate, Karidia
Lindberg, Mattias F.
Jourdan, Carole
Telmar, Anthony
Seisel, Quentin
Fernandez, Frédéric
Viguier, Véronique
Genevois, Coralie
Couillaud, Franck
Boisguerin, Prisca
Deshayes, Sébastien
author_facet Vaissière, Anaïs
Aldrian, Gudrun
Konate, Karidia
Lindberg, Mattias F.
Jourdan, Carole
Telmar, Anthony
Seisel, Quentin
Fernandez, Frédéric
Viguier, Véronique
Genevois, Coralie
Couillaud, Franck
Boisguerin, Prisca
Deshayes, Sébastien
author_sort Vaissière, Anaïs
collection PubMed
description BACKGROUND: Small interfering RNAs (siRNAs) are powerful tools to control gene expression. However, due to their poor cellular permeability and stability, their therapeutic development requires a specific delivery system. Among them, cell-penetrating peptides (CPP) have been shown to transfer efficiently siRNA inside the cells. Recently we developed amphipathic peptides able to self-assemble with siRNAs as peptide-based nanoparticles and to transfect them into cells. However, despite the great potential of these drug delivery systems, most of them display a low resistance to proteases. RESULTS: Here, we report the development and characterization of a new CPP named RICK corresponding to the retro-inverso form of the CADY-K peptide. We show that RICK conserves the main biophysical features of its L-parental homologue and keeps the ability to associate with siRNA in stable peptide-based nanoparticles. Moreover the RICK:siRNA self-assembly prevents siRNA degradation and induces inhibition of gene expression. CONCLUSIONS: This new approach consists in a promising strategy for future in vivo application, especially for targeted anticancer treatment (e.g. knock-down of cell cycle proteins). [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12951-017-0269-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5410048
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54100482017-05-02 A retro-inverso cell-penetrating peptide for siRNA delivery Vaissière, Anaïs Aldrian, Gudrun Konate, Karidia Lindberg, Mattias F. Jourdan, Carole Telmar, Anthony Seisel, Quentin Fernandez, Frédéric Viguier, Véronique Genevois, Coralie Couillaud, Franck Boisguerin, Prisca Deshayes, Sébastien J Nanobiotechnology Research BACKGROUND: Small interfering RNAs (siRNAs) are powerful tools to control gene expression. However, due to their poor cellular permeability and stability, their therapeutic development requires a specific delivery system. Among them, cell-penetrating peptides (CPP) have been shown to transfer efficiently siRNA inside the cells. Recently we developed amphipathic peptides able to self-assemble with siRNAs as peptide-based nanoparticles and to transfect them into cells. However, despite the great potential of these drug delivery systems, most of them display a low resistance to proteases. RESULTS: Here, we report the development and characterization of a new CPP named RICK corresponding to the retro-inverso form of the CADY-K peptide. We show that RICK conserves the main biophysical features of its L-parental homologue and keeps the ability to associate with siRNA in stable peptide-based nanoparticles. Moreover the RICK:siRNA self-assembly prevents siRNA degradation and induces inhibition of gene expression. CONCLUSIONS: This new approach consists in a promising strategy for future in vivo application, especially for targeted anticancer treatment (e.g. knock-down of cell cycle proteins). [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12951-017-0269-2) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-28 /pmc/articles/PMC5410048/ /pubmed/28454579 http://dx.doi.org/10.1186/s12951-017-0269-2 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Vaissière, Anaïs
Aldrian, Gudrun
Konate, Karidia
Lindberg, Mattias F.
Jourdan, Carole
Telmar, Anthony
Seisel, Quentin
Fernandez, Frédéric
Viguier, Véronique
Genevois, Coralie
Couillaud, Franck
Boisguerin, Prisca
Deshayes, Sébastien
A retro-inverso cell-penetrating peptide for siRNA delivery
title A retro-inverso cell-penetrating peptide for siRNA delivery
title_full A retro-inverso cell-penetrating peptide for siRNA delivery
title_fullStr A retro-inverso cell-penetrating peptide for siRNA delivery
title_full_unstemmed A retro-inverso cell-penetrating peptide for siRNA delivery
title_short A retro-inverso cell-penetrating peptide for siRNA delivery
title_sort retro-inverso cell-penetrating peptide for sirna delivery
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410048/
https://www.ncbi.nlm.nih.gov/pubmed/28454579
http://dx.doi.org/10.1186/s12951-017-0269-2
work_keys_str_mv AT vaissiereanais aretroinversocellpenetratingpeptideforsirnadelivery
AT aldriangudrun aretroinversocellpenetratingpeptideforsirnadelivery
AT konatekaridia aretroinversocellpenetratingpeptideforsirnadelivery
AT lindbergmattiasf aretroinversocellpenetratingpeptideforsirnadelivery
AT jourdancarole aretroinversocellpenetratingpeptideforsirnadelivery
AT telmaranthony aretroinversocellpenetratingpeptideforsirnadelivery
AT seiselquentin aretroinversocellpenetratingpeptideforsirnadelivery
AT fernandezfrederic aretroinversocellpenetratingpeptideforsirnadelivery
AT viguierveronique aretroinversocellpenetratingpeptideforsirnadelivery
AT genevoiscoralie aretroinversocellpenetratingpeptideforsirnadelivery
AT couillaudfranck aretroinversocellpenetratingpeptideforsirnadelivery
AT boisguerinprisca aretroinversocellpenetratingpeptideforsirnadelivery
AT deshayessebastien aretroinversocellpenetratingpeptideforsirnadelivery
AT vaissiereanais retroinversocellpenetratingpeptideforsirnadelivery
AT aldriangudrun retroinversocellpenetratingpeptideforsirnadelivery
AT konatekaridia retroinversocellpenetratingpeptideforsirnadelivery
AT lindbergmattiasf retroinversocellpenetratingpeptideforsirnadelivery
AT jourdancarole retroinversocellpenetratingpeptideforsirnadelivery
AT telmaranthony retroinversocellpenetratingpeptideforsirnadelivery
AT seiselquentin retroinversocellpenetratingpeptideforsirnadelivery
AT fernandezfrederic retroinversocellpenetratingpeptideforsirnadelivery
AT viguierveronique retroinversocellpenetratingpeptideforsirnadelivery
AT genevoiscoralie retroinversocellpenetratingpeptideforsirnadelivery
AT couillaudfranck retroinversocellpenetratingpeptideforsirnadelivery
AT boisguerinprisca retroinversocellpenetratingpeptideforsirnadelivery
AT deshayessebastien retroinversocellpenetratingpeptideforsirnadelivery